Methyl (5-(4-fluorobenzoyl)-1H-benzo[d]imidazol-2-yl)carbamate

Catalog No. :
ACSBOG682
CAS No. :
31430-15-6
Molecular Formula :
C16H12FN3O3
Molecular Weight :
313.29

IUPAC Name:methyl (5-(4-fluorobenzoyl)-1H-benzo[d]imidazol-2-yl)carbamate

Methyl (5-(4-fluorobenzoyl)-1H-benzo[d]imidazol-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$100.00Login to see priceIn stockIn stock
100g98%$327.00Login to see priceIn stockIn stock
500g98%$1308.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (5-(4-fluorobenzoyl)-1H-benzo[d]imidazol-2-yl)carbamate
IUPAC Namemethyl (5-(4-fluorobenzoyl)-1H-benzo[d]imidazol-2-yl)carbamate
MDL No.MFCD00871999
Molecular FormulaC16H12FN3O3
Molecular Weight313.29
SMILESO=C(OC)NC1=NC2=CC(C(C3=CC=C(F)C=C3)=O)=CC=C2N1
InChI KeyCPEUVMUXAHMANV-UHFFFAOYSA-N
SynonymAB00639981-06 | DB08974 | FLUBENDAZOLE [USAN] | HMS2090I16 | MLS006010905 | DTXSID8023058 | Flubendazol [INN-Spanish] | FLUBENDAZOLE [MART.] | Flubendazolum | Fluvermal | Q-201119 | SR-01000759412 | HY-B0294 | NC00137 | SCHEMBL167185 | Flumoxane | CCG-267
CAS No.31430-15-6
PubChem CID35802

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSBOG682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSBOG682 route product structure diagram
    ACSBOG68231430-15-6 In Stock
Inquiry

2. ACSBOG682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSBOG682 route product structure diagram
    ACSBOG68231430-15-6 In Stock
Inquiry

Comments (0)